On Monday, Following Stocks were among the “Top 100 Gainers” In U.S. Stock Exchange: Vascular Biogenics Ltd (NASDAQ:VBLT), Atlas Resource Partners, L.P (NYSE:ARP), Genworth Financial Inc (NYSE:GNW), Freeport-McMoRan Inc (NYSE:FCX)
Vascular Biogenics Ltd (NASDAQ:VBLT)’s shares picked up 5.22%, and closed at $6.05. The stock has price to book ratio of 3.13. With recent incline, the year-to-date (YTD) performance reflected a 2.37% gain above last year. During the past month the stocks gain 48.28%, bringing three-month performance to -6.92% and six-month performance to -45.74%. The mean recommendation of analysts for this stock is 2.70. (where 1=Buy, 5=Sale).
Vascular Biogenics Ltd., a clinical-stage biopharmaceutical company, is engaged in the discovery, development, and commercialization of treatments for cancer and immune-inflammatory diseases. Its lead product candidates comprise VB-111, a gene-based biologic, which is in Phase II clinical trials for the treatment of recurrent glioblastoma, an aggressive form of brain cancer; in Phase II clinical trials to treat thyroid cancer; and in Phase I/II clinical trials for the treatment of ovarian cancer, in addition to VB-201, an oral small molecule that is in Phase II clinical trials for the treatment psoriasis and ulcerative colitis. The company was formerly known as Medicard Ltd. and changed its name to Vascular Biogenics Ltd. in January 2003. Vascular Biogenics Ltd. was founded in 2000 and is headquartered in Or Yehuda, Israel.
Atlas Resource Partners, L.P (NYSE:ARP), raised 5.20%, and closed at $7.69. The company holds the market capitalization of $624.15M. For the last twelve months, the stock was able to keep return on equity at -64.50%, while return on assets at -23.00%, in response to its return on investment at -25.70%. Its 20-day moving average declined -12.79%, below 50-day moving average of -16.25%, below 200-day moving average of -46.17% from the latest market price of $7.69. The mean recommendation of analysts for this stock is 2.20.(where 1=Buy, 5=Sale).
Atlas Resource Partners, L.P. operates as an independent developer and producer of natural gas, crude oil, and natural gas liquids in the United States. The company operates in three segments: Gas and Oil Production, Well Construction and Completion, and Other Partnership Administration. As of March 2, 2015, it owned an interest in about 14,500 producing natural gas and oil wells located primarily in Appalachia, the Barnett Shale (Texas), the Mississippi Lime (Oklahoma), the Raton Basin (New Mexico), Black Warrior Basin (Alabama), and the oil-rich Rangely Field (Colorado). The company had estimated proved reserves of 1,429 billion cubic feet equivalent. In addition, it sponsors and manages tax-advantaged investment natural gas and oil partnerships. The company was founded in 2011 and is based in Pittsburgh, Pennsylvania.
Genworth Financial Inc (NYSE:GNW), enhanced 5.01%, and closed at $7.74. The stock volatility for the week is 3.39%, while for the month remained 3.91%. The company holds consensus target price of $11.22.
If we consider EPS growth of the company, then the company indicated the following observations:
The company showed -2.52 diluted EPS growth for trailing twelve months. However, YTD EPS growth remained -318.30% and Annual EPS growth for the past 5 years is considered as -17.50%.
The mean recommendation of analysts for this stock is 2.40. (where 1=Buy, 5=Sale).
Genworth Financial, Inc. provides insurance, retirement, and homeownership solutions in the United States and internationally. It operates through U.S. Life Insurance, International Mortgage Insurance, U.S. Mortgage Insurance, International Protection, and Runoff segments. The U.S. Life Insurance segment offers and manages various life insurance, long-term care insurance, and fixed annuity products. The International Mortgage Insurance segment provides mortgage insurance products and related services in Canada and Australia, in addition to participates in select European and other countries. Its products insure prime-based, individually underwritten residential mortgage loans, also known as flow mortgage insurance.
Freeport-McMoRan Inc (NYSE:FCX), rose 5.00%, and closed at $19.33. The company has the market capitalization of $19.14B. The beta value of the stock is 2.25. On the other hand the stock’s volatility for the week is 5.97%, and for the month is 4.14%. The stock’s price to book ratio is 1.10, however price to sale ratio is 0.94. Analyst’s mean recommendation regarding this stock is 2.40. (where 1=Buy, 5=Sale).
Freeport-McMoRan Inc., a natural resource company, engages in the attainment of mineral assets, and oil and natural gas resources. It primarily explores for copper, gold, molybdenum, cobalt, silver, and other metals, in addition to oil and gas. The company operates through North America Copper Mines; South America Mining; Indonesia Mining; Africa Mining; Molybdenum Mines; United States (U.S.) Oil and Gas Operations; Rod & Refining; and Atlantic Copper Smelting & Refining segments. It holds interests in various mines located in the Grasberg minerals district in Indonesia; Morenci, Bagdad, Safford, Sierrita, Miami, Chino, Tyrone, Henderson, and Climax in North America; Cerro Verde and El Abra in South America; and Tenke Fungurume minerals district in Africa.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The data demonstrated in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
